Sulfolipid deficiency does not affect the virulence of Mycobacterium tuberculosis H37Rv in mice and guinea pigs

Infection and Immunity

Volumn 71, Issue 8, 2003, Pages 4684-4690

  Rousseau, Cécile ^a   Turner, Oliver C ^b   Rush, Erik ^b   Bordat, Yann ^a   Sirakova, Tatiana D ^c   Kolattukudy, Pappachan E ^c   Ritter, Shannon ^d   Orme, Ian M ^b   Gicquel, Brigitte ^a   Jackson, Mary ^a  

^a INSTITUT PASTEUR   (France)

^b Department of Environmental and Radiological Health Sciences   (United States)

^c UNIVERSITY OF CENTRAL FLORIDA   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; LIPID; SULFOLIPID; UNCLASSIFIED DRUG; VIRULENCE FACTOR;

ADOLESCENT; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BACTERIAL MEMBRANE; BACTERIAL SURVIVAL; BACTERIAL VIRULENCE; BACTERIUM MUTANT; CELL DIVISION; GUINEA PIG; HUMAN; MOUSE; MYCOBACTERIOSIS; MYCOBACTERIUM TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS H37RV; NONHUMAN; PATHOGENESIS; PATHOGENICITY; PERSISTENT INFECTION; PHAGOCYTE; PRIORITY JOURNAL;

ANIMALS; CELL LINE; FEMALE; GUINEA PIGS; HUMANS; HYPERSENSITIVITY, DELAYED; IMMUNITY, CELLULAR; LIPID METABOLISM; LIPIDS; LUNG; MACROPHAGES; MICE; MICE, INBRED BALB C; MUTATION; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS, PULMONARY; VIRULENCE;

EID: 0043267443     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.71.8.4684-4690.2003     Document Type: Article

References (28)

1. Bardarov, S., J. Kriakov, C. Carriere, S. Yu, C. Vaamonde, R. A. M. Adam, B. R. Bloom, G. F. Hatfull, and W. R. Jacobs, Jr. 1997. Conditionally replicating mycobacteriophages: a system for transposon delivery to Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA 94:10961-10966.
2. Brozna, J. P., M. Horan, J. M. Rademacher, K. M. Pabst, and M. J. Pabst. 1991. Monocyte responses to sulfolipid from Mycobacterium tuberculosis: inhibition of priming for enhanced release of superoxide, associated with increased secretion of interleukin-1 and tumor necrosis factor alpha and altered protein phosphorylation. Infect. Immun. 59:2542-2548.
3. Camacho, L. R., D. Ensergueix, E. Perez, B. Gicquel, and C. Guilhot. 1999. Identification of a virulence gene cluster of Mycobacterium tuberculosis by signature-tagged transposon mutagenesis. Mol. Microbiol. 34:257-267.
4. Cox, J. S., B. Chen, M. McNeil, and W. R. Jacobs, Jr. 1999. Complex lipid determines tissue-specific replication of Mycobacterium tuberculosis in mice. Nature 402:79-83.
5. D'Arcy Hart, P., and M. R. Young. 1988. Poiyanionic agents inhibit phagosome-lysosome fusion in cultured macrophages: a reply to the suggestion of Goren, Vatter, and Fiscus to the contrary. J. Leukoc. Biol. 43:179-182.
6. Deretic, V., and R. A. Fratti. 1999. Mycobacterium tuberculosis phagosome. Mol. Microbiol. 31:1603-1609.
7. Dubos, R. J., and G. Middlebrook. 1948. Cytochemical reaction of virulent tubercle bacilli. Am. Rev. Tuberc. 58:698-699.
8. Gangadharam, P. R. J., M. L. Cohn, and G. Middlebrook. 1963. Infectivity, pathogenicity and sulpholipid fraction of some Indian and British strains of tubercle bacilli. Tubercle 44:452-455.
9. Goren, M. B. 1990. Mycobacterial fatty acid esters of sugars and sulfosugars, p. 363-461. In M. Kates (ed.), Handbook of lipid research: glycolipids, phosphoglycolipids and sulfoglycolipids, vol. 6. Plenum Press, New York, N.Y.
10. Goren, M. B. 1970. Sulfolipid I of Mycobacterium tuberculosis, strain H37Rv. Purification and properties. Biochim. Biophys. Acta 210:116-126.
11. Goren, M. B., and P. J. Brennan. 1979. Mycobacterial lipids: chemistry and biologic activities, p. 63-193. In G. P. Youmans (ed.), Tuberculosis. W. B. Saunders Company, Philadelphia, Pa.
12. Goren, M. B., O. Brokl, and W. B. Schaefer. 1974. Lipids of putative relevance to virulence in Mycobacterium tuberculosis: correlation of virulence with elaboration of sulfatides and strongly acidic lipids. Infect. Immun. 9:142-149.
13. Goren, M. B., O. Brokl, and W. B. Schaefer. 1974. Lipids of putative relevance to virulence in Mycobacterium tuberculosis: phthiocerol dimycocerosate and the attenuation indicator lipid. Infect. Immun. 9:150-158.
14. Goren, M. B., P. D'Arcy Hart, M. R. Young, and J. A. Armstrong. 1976. Prevention of phagosome-lysosome fusion in cultured macrophages by sulfatides of Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA 73:2510-2514.
15. Goren, M. B., J. M. Grange, V. R. Aber, B. W. Allen, and D. A. Mitchinson. 1982. Role of lipid content and hydrogen peroxyde susceptibility in determining the guinea-pig virulence of Mycobacterium tuberculosis. Br. J. Exp. Pathol. 63:693-700.
16. Goren, M. B., A. E. Vatter, and J. Fiscus. 1987. Polyanionic agents do not inhibit phagosome-lysosome fusion in cultured macrophages. J. Leukoc. Biol. 41:122-129.
17. Graham, J. E., and J. E. Clark-Curtiss. 1999. Identification of Mycobacterium tuberculosis RNAs synthesized in response to phagocytosis by human macrophages by selective capture of transcribed sequences (SCOTS). Proc. Natl. Acad. Sci. USA 96:11554-11559.
18. Grange, J. M., V. R. Aber, B. W. Allen, D. A. Mitchinson, and M. B. Goren. 1978. The correlation of bacteriophage types of Mycobacterium tuberculosis with guinea-pig virulence and in vitro-indicators of virulence. J. Gen. Microbiol. 108:1-7.
19. Kato, M., and M. B. Goren. 1974. Synergistic action of cord factor and mycobacterial sulfatides on mitochondria. Infect. Immun. 10:733-741.
20. Middlebrook, G., C. M. Coleman, and W. B. Schaefer. 1959. Sulfolipid from virulent tubercle bacilli. Proc. Natl. Acad. Sci. USA 45:1801-1804.
21. Middlebrook, G., R. J. Dubos, and C. Pierce. 1947. Virulence and morphological characteristics of mammalian tubercle bacilli. J. Exp. Med. 86:175-187.
22. Pabst, M. J., J. M. Gross, J. P. Brozna, and M. B. Goren. 1988. Inhibition of macrophage priming by sulfatide from Mycobacterium tuberculosis. J. Immunol. 140:634-640.
23. Pelicic, V., M. Jackson, J. M. Reyrat, W. R. Jacobs, Jr., B. Gicquel, and C. Guilhot. 1997. Efficient allelic exchange and transposon mutagenesis in Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA 94:10955-10960.
24. Sirakova, T. D., A. K. Thirumala, V. S. Dubey, H. Sprecher, and P. E. Kolattukudy. 2001. The Mycobacterium tuberculosis pks2 gene encodes the synthase for the hepta- and octamethyl branched fatty acids required for sulfolipid synthesis. J. Biol. Chem. 276:16833-16839.
25. Turner, O. C., R. J. Basaraba, and I. M. Orme. 2003. Immunopathogenesis of pulmonary granulomas in guinea pig following infection with Mycobacterium tuberculosis. Infect. Immun. 71:864-871.
26. World Health Organization. 2002. Tuberculosis fact sheet no. 104. http: //www.who.int/mediacentre/factsheets/who104/en/index.html. (Online.)
27. Zhang, L., D. English, and B. R. Andersen. 1991. Activation of human neutrophils by Mycobacterium tuberculosis-derived sulfolipid I. J. Immunol. 146:2730-2736.
28. Zhang, L., M. B. Goren, T. J. Holzer, and B. R. Andersen. 1988. Effect of Mycobacterium tuberculosis-derived sulfolipid I on human phagocytic cells. Infect. Immun. 56:2876-2883.